Details of the Drug

General Information of Drug (ID: DM3V5AB)

Drug Name

2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol

Synonyms

CHEMBL1090794; 2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol; SCHEMBL1240366

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

361.4

Logarithm of the Partition Coefficient (xlogp)

1.6

Rotatable Bond Count (rotbonds)

5

Hydrogen Bond Donor Count (hbonddonor)

1

Hydrogen Bond Acceptor Count (hbondacc)

5

Chemical Identifiers

Formula: C22H23N3O2
IUPAC Name: 2-morpholin-4-yl-2-phenyl-1,1-dipyridin-3-ylethanol
Canonical SMILES: C1COCCN1C(C2=CC=CC=C2)C(C3=CN=CC=C3)(C4=CN=CC=C4)O
InChI: InChI=1S/C22H23N3O2/c26-22(19-8-4-10-23-16-19,20-9-5-11-24-17-20)21(18-6-2-1-3-7-18)25-12-14-27-15-13-25/h1-11,16-17,21,26H,12-15H2
InChIKey: WPLZJOHYEBBPRT-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Voltage-gated potassium channel Kv1.5 (KCNA5)	TTW0CMT	KCNA5_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2493-6.